In vitro diagnostic (IVD) testing is experiencing a revival fueled by a combination of technological improvements, cost pressures, reimbursement changes, rapid growth in molecular diagnostics and increasing interest in the genomics testing.
Scope of the Report:
Recent advances in molecular diagnostics technologies--including sequencing, PCR and microarray--are enabling greater sensitivity and precision in nucleic acid measurements, further expanding manufacturers' offerings.
The global IVD (In Vitro Diagnostic) Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of IVD (In Vitro Diagnostic) Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the IVD (In Vitro Diagnostic) Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the IVD (In Vitro Diagnostic) Testing market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche Diagnostics (Switzerland)
Siemens Healthineers (Germany)
Danaher (US)
Abbott Laboratories (US)
Thermo Fisher Scientific (US)
Johnson & Johnson (US)
Becton
Dickinson (US)
Bio-Rad Laboratories (US)
Sysmex (Japan)
BiomeRieux (France)
DiaSorin (Italy)
Ortho Clinical Diagnostics (US)
QIAGEN (Germany)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Instruments
Reagents
Market Segment by Applications, can be divided into
Hospitals
Commercial/Private Labs
Physician Offices
Public Health Labs
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 IVD (In Vitro Diagnostic) Testing Market Overview
1.1 Product Overview and Scope of IVD (In Vitro Diagnostic) Testing
1.2 Classification of IVD (In Vitro Diagnostic) Testing by Types
1.2.1 Global IVD (In Vitro Diagnostic) Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global IVD (In Vitro Diagnostic) Testing Revenue Market Share by Types in 2017
1.2.3 Instruments
1.2.4 Reagents
1.3 Global IVD (In Vitro Diagnostic) Testing Market by Application
1.3.1 Global IVD (In Vitro Diagnostic) Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Commercial/Private Labs
1.3.4 Physician Offices
1.3.5 Public Health Labs
1.4 Global IVD (In Vitro Diagnostic) Testing Market by Regions
1.4.1 Global IVD (In Vitro Diagnostic) Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) IVD (In Vitro Diagnostic) Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) IVD (In Vitro Diagnostic) Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) IVD (In Vitro Diagnostic) Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) IVD (In Vitro Diagnostic) Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) IVD (In Vitro Diagnostic) Testing Status and Prospect (2013-2023)
1.5 Global Market Size of IVD (In Vitro Diagnostic) Testing (2013-2023)
2 Manufacturers Profiles
2.1 Roche Diagnostics (Switzerland)
2.1.1 Business Overview
2.1.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Diagnostics (Switzerland) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Siemens Healthineers (Germany)
2.2.1 Business Overview
2.2.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Siemens Healthineers (Germany) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Danaher (US)
2.3.1 Business Overview
2.3.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Danaher (US) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott Laboratories (US)
2.4.1 Business Overview
2.4.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Laboratories (US) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Thermo Fisher Scientific (US)
2.5.1 Business Overview
2.5.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Thermo Fisher Scientific (US) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson (US)
2.6.1 Business Overview
2.6.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson (US) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Becton
2.7.1 Business Overview
2.7.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Becton IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Dickinson (US)
2.8.1 Business Overview
2.8.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dickinson (US) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bio-Rad Laboratories (US)
2.9.1 Business Overview
2.9.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bio-Rad Laboratories (US) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sysmex (Japan)
2.10.1 Business Overview
2.10.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sysmex (Japan) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 BiomeRieux (France)
2.11.1 Business Overview
2.11.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 BiomeRieux (France) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 DiaSorin (Italy)
2.12.1 Business Overview
2.12.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 DiaSorin (Italy) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Ortho Clinical Diagnostics (US)
2.13.1 Business Overview
2.13.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Ortho Clinical Diagnostics (US) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.14 QIAGEN (Germany)
2.14.1 Business Overview
2.14.2 IVD (In Vitro Diagnostic) Testing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 QIAGEN (Germany) IVD (In Vitro Diagnostic) Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global IVD (In Vitro Diagnostic) Testing Market Competition, by Players
3.1 Global IVD (In Vitro Diagnostic) Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 IVD (In Vitro Diagnostic) Testing Players Market Share
3.2.2 Top 10 IVD (In Vitro Diagnostic) Testing Players Market Share
3.3 Market Competition Trend
4 Global IVD (In Vitro Diagnostic) Testing Market Size by Regions
4.1 Global IVD (In Vitro Diagnostic) Testing Revenue and Market Share by Regions
4.2 North America IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
4.3 Europe IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
4.5 South America IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
5 North America IVD (In Vitro Diagnostic) Testing Revenue by Countries
5.1 North America IVD (In Vitro Diagnostic) Testing Revenue by Countries (2013-2018)
5.2 USA IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
5.3 Canada IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
6 Europe IVD (In Vitro Diagnostic) Testing Revenue by Countries
6.1 Europe IVD (In Vitro Diagnostic) Testing Revenue by Countries (2013-2018)
6.2 Germany IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
6.3 UK IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
6.4 France IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
6.5 Russia IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
6.6 Italy IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific IVD (In Vitro Diagnostic) Testing Revenue by Countries
7.1 Asia-Pacific IVD (In Vitro Diagnostic) Testing Revenue by Countries (2013-2018)
7.2 China IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
7.3 Japan IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
7.4 Korea IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
7.5 India IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
8 South America IVD (In Vitro Diagnostic) Testing Revenue by Countries
8.1 South America IVD (In Vitro Diagnostic) Testing Revenue by Countries (2013-2018)
8.2 Brazil IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue IVD (In Vitro Diagnostic) Testing by Countries
9.1 Middle East and Africa IVD (In Vitro Diagnostic) Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
9.3 UAE IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa IVD (In Vitro Diagnostic) Testing Revenue and Growth Rate (2013-2018)
10 Global IVD (In Vitro Diagnostic) Testing Market Segment by Type
10.1 Global IVD (In Vitro Diagnostic) Testing Revenue and Market Share by Type (2013-2018)
10.2 Global IVD (In Vitro Diagnostic) Testing Market Forecast by Type (2018-2023)
10.3 Instruments Revenue Growth Rate (2013-2023)
10.4 Reagents Revenue Growth Rate (2013-2023)
11 Global IVD (In Vitro Diagnostic) Testing Market Segment by Application
11.1 Global IVD (In Vitro Diagnostic) Testing Revenue Market Share by Application (2013-2018)
11.2 IVD (In Vitro Diagnostic) Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Commercial/Private Labs Revenue Growth (2013-2018)
11.5 Physician Offices Revenue Growth (2013-2018)
11.6 Public Health Labs Revenue Growth (2013-2018)
12 Global IVD (In Vitro Diagnostic) Testing Market Size Forecast (2018-2023)
12.1 Global IVD (In Vitro Diagnostic) Testing Market Size Forecast (2018-2023)
12.2 Global IVD (In Vitro Diagnostic) Testing Market Forecast by Regions (2018-2023)
12.3 North America IVD (In Vitro Diagnostic) Testing Revenue Market Forecast (2018-2023)
12.4 Europe IVD (In Vitro Diagnostic) Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific IVD (In Vitro Diagnostic) Testing Revenue Market Forecast (2018-2023)
12.6 South America IVD (In Vitro Diagnostic) Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa IVD (In Vitro Diagnostic) Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure IVD (In Vitro Diagnostic) Testing Picture
Table Product Specifications of IVD (In Vitro Diagnostic) Testing
Table Global IVD (In Vitro Diagnostic) Testing and Revenu